Effects of vitamin E on chronic and acute endothelial dysfunction in smokers
Thomas Neunteufl, MDa,
Ute Priglinger, MDa,
Sandra Heher, MDa,
Manfred Zehetgruber, MDa,
Gabor Söregi, MD*,
Stephan Lehr ,
Kurt Huber, MDa,
Gerald Maurer, MD, FACCa,
Franz Weidinger, MD and
Karam Kostner, MDa
a Department of Cardiology, University of Vienna, Vienna, Austria
* Department of Clinical Chemistry, University of Vienna, Vienna, Austria
Institute for Medical Statistics, University of Vienna, Vienna, Austria
Department of Cardiology, University of Innsbruck, Innsbruck, Austria

View larger version (14K):
[in a new window]
|
Figure 1 Bar graph showing FMD values of subjects receiving placebo and of subjects receiving vitamin E (600 IU/day) at baseline, after therapy for four weeks and after heavy smoking at the end of the treatment period. Time factor p value = 0.0065. Group factor p value = 0.5834. Interaction of the time factor and the grouping factor: p = 0.0318. FMD = flow-mediated vasodilation. Open square = placebo; closed square = Vitamin E.
|
|

View larger version (16K):
[in a new window]
|
Figure 2 FMD values before and after heavy smoking at the end of the treatment period for subjects receiving placebo as well as for subjects receiving vitamin E (600 IU/day). P values for the time factor = 0.0001; p value for the group factor = 0.0017. FMD = flow-mediated vasodilation.
|
|

View larger version (9K):
[in a new window]
|
Figure 3 Transient impairment of FMD (delta FMD) after heavy smoking vs. improvement of the antioxidant status (delta TBARS) under vitamin E supplementation for four weeks. FMD = flow-mediated dilation; TBARS = thiobarbituric acid-reactive substances.
|
|
|